Diabetic Neuropathy in the Foot: Symptoms, Testing, and Managing Nerve Damage

✅ Medically reviewed by Dr. Tom Biernacki, DPM — Board-certified podiatrist specializing in foot & ankle surgery. View credentials.

What Is Diabetic Peripheral Neuropathy? For specialized treatment, see our neuropathy foot care at Balance Foot & Ankle.

Diabetic peripheral neuropathy (DPN) is the most common complication of diabetes—affecting approximately 50% of people with type 2 diabetes after 10 years and up to 70% at 25 years. It results from damage to the peripheral nerves (the nerves that carry signals between the brain, spinal cord, and the rest of the body) caused by chronically elevated blood glucose. High glucose damages the small blood vessels supplying nerves (vasa nervorum), impairing oxygen and nutrient delivery. The longest nerves in the body—those supplying the feet—are affected first, producing the characteristic “stocking-and-glove” distribution of symptoms starting in the toes and feet.

DPN is clinically significant for two opposing reasons: it causes pain (painful neuropathy—burning, shooting, electric sensations in the feet), and it causes the absence of pain (loss of protective sensation—the inability to feel injury, which allows wounds to go undetected and progress to ulceration and amputation). Both manifestations require different management approaches.

Symptoms: What Patients Notice First

Early diabetic neuropathy typically begins with subtle sensory changes in the toes and ball of the foot: tingling, prickling, or “pins and needles” sensations, particularly at rest and at night. Some patients notice a feeling of “walking on cotton” or reduced sensation in the feet. Others experience the opposite—increased sensitivity where even light touch is painful (allodynia). As neuropathy progresses, symptoms typically move proximally up the foot and leg in a stocking distribution.

Painful diabetic neuropathy produces burning, stabbing, electric, or aching pain in the feet and lower legs—typically worse at night and with rest. Paradoxically, neuropathic pain does not indicate preserved protective sensation—a patient can have significant pain and simultaneously have lost the ability to feel a wound. Loss of protective sensation (the inability to feel a 5.07 monofilament) places the foot at high risk for ulceration regardless of whether painful symptoms are present.

How Diabetic Neuropathy Is Tested

Podiatric evaluation of diabetic neuropathy uses several validated clinical tools. The Semmes-Weinstein 5.07 monofilament test applies a standardized pressure to specific foot locations—inability to feel the monofilament at one or more sites indicates loss of protective sensation (LOPS). Vibration threshold testing with a 128 Hz tuning fork assesses large fiber sensation. Pinprick testing assesses small fiber (pain) sensation. Ankle reflexes are reduced or absent in advanced neuropathy. These tests together define the neuropathy severity and guide foot care intensity—patients who cannot feel the monofilament require aggressive preventive care, therapeutic footwear, and more frequent podiatric surveillance.

Nerve conduction velocity (NCV) studies performed by neurologists quantify the speed and amplitude of nerve signal transmission. NCV is the gold standard for diagnosing and characterizing peripheral neuropathy but is less practical for routine screening. Intraepidermal nerve fiber density (IENFD) biopsy is the most sensitive test for small fiber neuropathy that may be missed on standard NCV. Autonomic neuropathy (affecting the small fibers controlling sweat glands and skin moisture) causes dry, cracked skin on the feet that creates entry points for infection—a clinical sign visible during examination.

Treatment: Managing Neuropathic Pain and Protecting the Foot

Glycemic Control: The Foundation

Optimizing blood glucose control slows neuropathy progression and is the most important long-term management intervention. In type 1 diabetes, intensive glycemic control substantially reduces neuropathy incidence. In type 2 diabetes, the benefit is more modest but still meaningful. Target HbA1c below 7.0% (or individualized targets based on patient circumstances) is the general guideline. Neuropathy that has already developed does not fully reverse with improved glucose control, but progression can be significantly slowed.

Medications for Neuropathic Pain

FDA-approved medications for diabetic neuropathic pain include: duloxetine (Cymbalta)—a serotonin-norepinephrine reuptake inhibitor (SNRI) effective for neuropathic pain and depression; pregabalin (Lyrica)—a calcium channel ligand that reduces aberrant nerve signaling; and tapentadol (Nucynta ER). Commonly used off-label options include gabapentin (Neurontin), tricyclic antidepressants (amitriptyline—effective but limited by side effects in older adults), and topical agents (capsaicin cream, lidocaine patches) for localized pain. Opioids are generally not recommended for chronic neuropathic pain management given poor long-term outcomes and abuse potential.

Foot Protection

When protective sensation is lost, external protective measures replace the absent pain signal. Diabetic therapeutic footwear (extra-depth shoes, custom molded insoles) distributes plantar pressure and prevents focal high-pressure areas that ulcerate. Daily foot inspection identifies wounds before they progress. Regular podiatric care (every 2–3 months) addresses calluses and nail problems that a neuropathic patient cannot safely manage at home. Patient and caregiver education about foot care is essential—many complications are prevented by simply knowing what to look for.

Frequently Asked Questions

Medical References & Sources

• PubMed Research — Diabetic Neuropathy Guidelines
• American Diabetes Association — Neuropathy
• PubMed Research — Neuropathic Pain Treatment

Dr. Tom Biernacki, DPM is a board-certified podiatric surgeon at Balance Foot & Ankle in Howell and Bloomfield Hills, Michigan. He provides comprehensive diabetic neuropathy assessment including monofilament testing, vibration threshold, and vascular evaluation, with preventive foot care and therapeutic footwear prescription for patients with loss of protective sensation.

Diabetic Neuropathy in Your Feet? Protect Them Now

Clinical References

1. Boulton AJ et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956-962.
2. Tesfaye S et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285-2293.
3. Singh N et al. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217-228.

Your Board-Certified Podiatrists

Dr. Tom Biernacki, DPM

Board-Certified · FACFAS

Dr. Carl Jay, DPM

Board-Certified Podiatrist

Dr. Daria Gutkin, DPM

Podiatrist

Dr. Tom Biernacki, DPM

Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.